NCT05636111 2026-01-22Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian CancerM.D. Anderson Cancer CenterPhase 1 Recruiting34 enrolled
NCT05578326 2025-07-08Study of Trilaciclib and LurbinectidinUNC Lineberger Comprehensive Cancer CenterPhase 2 Recruiting30 enrolled
NCT05800587 2025-04-04Dose Attenuated Chemotherapy in Compromised Patients With Lung CancerFox Chase Cancer CenterPhase 2 Recruiting280 enrolled